Brief: Auris Medical Announces Initiation Of Part B Of TRAVERS Phase 2 Study With AM-125 In Vertigo

Altamira Therapeutics

13/10/2020 14:42

Oct 13 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES INITIATION OF PART B OF TRAVERS
PHASE 2
STUDY WITH AM-125 IN VERTIGO
    * AURIS MEDICAL HOLDING LTD - EXPECTS TO COMPLETE ENROLLMENT
INTO
PART B OF TRAVERS TRIAL BY END OF Q1 2021

Source text for Eikon:  ID:nGNX8vPmlR 
Further company coverage:  EARS.O 

 (((Reuters.Briefs@thomsonreuters.com);))